Cargando…

Decline in Antimicrobial Consumption and Stagnation in Reducing Disease Burden due to Antimicrobial Resistance in Japan

INTRODUCTION: Antimicrobial resistance (AMR) is a major global health threat. While antimicrobial consumption (AMC) in Japan substantially decreased after implementation of the AMR National Action Plan, the disease burden due to AMR seems to be unchanged. The main objective of this study is to exami...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuzuki, Shinya, Koizumi, Ryuji, Matsunaga, Nobuaki, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390429/ https://www.ncbi.nlm.nih.gov/pubmed/37318709 http://dx.doi.org/10.1007/s40121-023-00829-7

Ejemplares similares

2259. Reversal of antimicrobial consumption: long-term impact of COVID-19 pandemic
por: Koizumi, Ryuji, et al.
Publicado: (2023)

Antimicrobial Use Fell Substantially in Japan in 2020—The COVID-19 Pandemic May Have Played a Role
por: Ono, Akane, et al.
Publicado: (2022)

Association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015–16 to 2020–21 seasons: from the VENUS study
por: Tsuzuki, Shinya, et al.
Publicado: (2023)

Evaluation of the Correspondence between the Concentration of Antimicrobials Entering Sewage Treatment Plant Influent and the Predicted Concentration of Antimicrobials Using Annual Sales, Shipping, and Prescriptions Data
por: Azuma, Takashi, et al.
Publicado: (2022)

Improved penicillin susceptibility of Streptococcus pneumoniae and increased penicillin consumption in Japan, 2013–18
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

233. Improved Penicillin Susceptibility of Streptococcus pneumoniae and Increased Penicillin Consumption in Japan, 2013–18
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

Cost of inappropriate antimicrobial use for upper respiratory infection in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

2201. Cost of Antimicrobial Use Against Upper Respiratory Infection in Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2019)

Effects of population age structure on parenteral antimicrobial use estimations
por: Koizumi, Ryuji, et al.
Publicado: (2023)

2032. First National Survey of Antimicrobial and Antifungal Stewardship in Japan
por: Moriyama, Yuki, et al.
Publicado: (2019)

Trends in healthcare visits and antimicrobial prescriptions for acute infectious diarrhea in individuals aged 65 years or younger in Japan from 2013 to 2018 based on administrative claims database: a retrospective observational study
por: Ono, Akane, et al.
Publicado: (2021)

908. Evaluation of Blood Culture Submission Rates in Japan
por: Tajima, Taichi, et al.
Publicado: (2020)

1295. Cross-sectional survey on education of clinical infectious diseases and antimicrobial resistance in pharmaceutical department in Japanese universities
por: Koizumi, Ryuji, et al.
Publicado: (2022)

Nationwide cross-sectional study of antimicrobial stewardship and antifungal stewardship programs in inpatient settings in Japan
por: Moriyama , Yuki, et al.
Publicado: (2021)

Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2022)

Regional trends in the use of steroids and favipiravir for COVID-19 treatment
por: Asai, Yusuke, et al.
Publicado: (2023)

1147. Regional Trends in Favipiravir and Steroid Use in the Treatment of COVID-19
por: Asai, Yusuke, et al.
Publicado: (2022)

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics
por: Saito, Sho, et al.
Publicado: (2021)

Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017
por: Kamata, Kazuhiro, et al.
Publicado: (2018)

Effects of the cefazolin shortage on the sales, cost, and appropriate use of other antimicrobials
por: Koizumi, Ryuji, et al.
Publicado: (2021)

Comparison of the clinical characteristics and outcomes of COVID-19 in children before and after the emergence of Delta variant of concern in Japan
por: Shoji, Kensuke, et al.
Publicado: (2022)

Comparison of de-duplication methods used by WHO Global Antimicrobial Resistance Surveillance System (GLASS) and Japan Nosocomial Infections Surveillance (JANIS) in the surveillance of antimicrobial resistance
por: Kajihara, Toshiki, et al.
Publicado: (2020)

Temporal trends in microbial detection during the COVID-19 pandemic: Analysis of the Japan surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) database
por: Endo, Akira, et al.
Publicado: (2023)

The first national survey of antimicrobial use among dentists in Japan from 2015 to 2017 based on the national database of health insurance claims and specific health checkups of Japan
por: Ono, Akane, et al.
Publicado: (2020)

Factors associated with sufficient knowledge of antibiotics and antimicrobial resistance in the Japanese general population
por: Tsuzuki, Shinya, et al.
Publicado: (2020)

Outcomes and Future Prospect of Japan’s National Action Plan on Antimicrobial Resistance (2016–2020)
por: Gu, Yoshiaki, et al.
Publicado: (2021)

158. National Cross-Sectional Study of Factors Influencing the Decision of Prescribing Penicillin as First Choice among Dentists in Japan
por: Koizumi, Ryuji, et al.
Publicado: (2021)

Impact of regional heterogeneity on the severity of COVID-19
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan
por: Terada, Mari, et al.
Publicado: (2021)

Characteristics and limitations of national antimicrobial surveillance according to sales and claims data
por: Kusama, Yoshiki, et al.
Publicado: (2021)

Effect of population inflow and outflow between rural and urban areas on regional antimicrobial use surveillance
por: Koizumi, Ryuji, et al.
Publicado: (2021)

Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan
por: Yoshihara, Fumiki, et al.
Publicado: (2022)

223. Difference in Carbapenem Use by ASP Intervention in Japanese Healthcare Facilities
por: Endo, Mio, et al.
Publicado: (2020)

Narrative Review: The Process of Expanding the Manual of Antimicrobial Stewardship by the Government of Japan
por: Jindai, Kazuaki, et al.
Publicado: (2020)

Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation
por: Yamada, Gen, et al.
Publicado: (2021)

2473. Trends in Methicillin Resistance Rate of Staphylococcus aureus among Medical Facilities Participating in Japan Nosocomial Infections Surveillance (JANIS)
por: Suzuki, Yuka, et al.
Publicado: (2019)

1785. Regional Variation of Antimicrobial Use in Japan From 2013 to 2016
por: Kusama, Yoshiki, et al.
Publicado: (2018)

National database study of trends in bacteraemia aetiology among children and adults in Japan: a longitudinal observational study
por: Kusama, Yoshiki, et al.
Publicado: (2021)

Influence of pharmacists and infection control teams or antimicrobial stewardship teams on the safety and efficacy of vancomycin: A Japanese administrative claims database study
por: Goto, Ryota, et al.
Publicado: (2022)

2778. Retrospective evaluation of effectiveness of Flomoxef for infections due to extended-spectrum β-lactamase-producing Enterobacterales
por: Koizumi, Ryuji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vp1hmrjlefbvspttuvc928khb4